Low-dose Maximal-intent Versus Controlled-tempo Resistance Training on Quality-of-life in Adults

Sponsor
Northumbria University (Other)
Overall Status
Completed
CT.gov ID
NCT06107855
Collaborator
(none)
20
1
2
7.9
2.5

Study Details

Study Description

Brief Summary

The aims of this study were to:
  1. Compare the effects of low-dose Maximal Intent and Controlled Tempo Resistance Training on untrained healthy adults' quality-of-life, functional capacity, and strength.

  2. Qualitatively explore perceptions of Maximal Intent and Controlled Tempo Resistance Training.

Condition or Disease Intervention/Treatment Phase
  • Other: Leg Press Resistance Training Machine
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Low-dose Maximal-intent Versus Controlled-tempo Resistance Training on Quality-of-life, Functional Capacity, and Strength in Untrained Healthy Adults: a Randomised Controlled Trial
Actual Study Start Date :
Aug 1, 2022
Actual Primary Completion Date :
Mar 29, 2023
Actual Study Completion Date :
Mar 29, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Maximal-intent Resistance Training

The MI group was instructed and encouraged to deliberately commit to exerting maximal effort and force during the concentric phase of the leg press with the intention of achieving the greatest velocity possible.

Other: Leg Press Resistance Training Machine
Participants used said unilateral leg press at 60% one-repetition max for either 3 sets x 5 reps, or 5 sets x 5 reps, at either maximal- or controlled-tempo-intent.

Experimental: Controlled-tempo Resistance Training

While the CT group followed the metronome for both eccentric and concentric phases.

Other: Leg Press Resistance Training Machine
Participants used said unilateral leg press at 60% one-repetition max for either 3 sets x 5 reps, or 5 sets x 5 reps, at either maximal- or controlled-tempo-intent.

Outcome Measures

Primary Outcome Measures

  1. Quality-of-life [The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.]

    Participant quality of life (focus group questions & SF-36)

Secondary Outcome Measures

  1. Balance [The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.]

    Using the biodex SD to do a 3 x 20s double-foot eyes-open balance test on Level 6.

  2. 6-minute Walk Test (6MWT) [The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.]

    a "brisk"-paced 6-minute walk test.

  3. Timed-up-and-go (TUG) [The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.]

    Standing from a chair, walking to a point 3 metres away, turn, and return to the chair as quick as possible whilst walking.

  4. 30-second sit-to-stand (30s-STS) [The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.]

    Maximal amount of repetitions a participant can stand up from a chair in 30-seconds.

  5. Strength (1RM) [The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.]

    Participants one-repetition max on leg press

  6. BMI [The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.]

    Additional measures calculated from participants test results

  7. Strength-to-mass [The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.]

    Additional measures calculated from participants test results

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 59 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Participants were eligible if they were between 30-60 years old

  • Uninjured

  • Had no cardiovascular or neuromuscular conditions

  • Had not participated in lower-limb RT in the previous six months.

Exclusion Criteria:
  • Participants were excluded if they had either taken part in any lower-limb RT in the last six months

  • Had underlying health condition(s) that prevented them from participating in RT

  • Regularly met or exceeded the UK recommended PA guideline of 150-minutes of moderate to intense PA per week.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nortuhmbria University Newcastle Tyne And Wear United Kingdom NE1 8ST

Sponsors and Collaborators

  • Northumbria University

Investigators

  • Principal Investigator: Gill Barry, PhD, Northumbria University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Northumbria University
ClinicalTrials.gov Identifier:
NCT06107855
Other Study ID Numbers:
  • 45459
First Posted:
Oct 30, 2023
Last Update Posted:
Oct 30, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Northumbria University

Study Results

No Results Posted as of Oct 30, 2023